| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D &CMO
1 company
Bernstein Harold is a President, R&D &CMO at Maze Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $382K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | MAZE Maze Therapeutics, Inc. | President, R&D &CMO | Sale+OE | 15,000 | $49.10 | $736,439.29 | -51.9% | - | - | |
| Mar 10, 2026 | MAZE Maze Therapeutics, Inc. | President, R&D &CMO | Sale+OE | 30,000 | $50.45 | $1,513,560.22 | -98.9% | - | - | |
| Jan 7, 2026 | MAZE Maze Therapeutics, Inc. | President, R&D &CMO | Sale+OE | 25,156 | $40.20 | $1,011,298.87 | -100% | -29.8% | - | |
| Jan 5, 2026 | MAZE Maze Therapeutics, Inc. | President, R&D &CMO | Sale+OE | 4,844 | $40.39 | $195,667.53 | -100% | -24.9% | - | |
| Dec 29, 2025 | MAZE Maze Therapeutics, Inc. | President, R&D &CMO | Sale+OE | 45,000 | $40.56 | $1,825,354.84 | -72.3% | -28.5% | - |